Assignee
LECLERC CLAUDE
FR·3 granted patents·4 pending applications·7 citations·filing 2004–2011
Top patents by PatentIndex Score
7 records- 0183US9095537B2Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune responseLECLERC CLAUDE·Filed 2007·Granted Aug 4, 2015·5 cites·32 claims
- 0269US9370564B2Vectors for molecule delivery to CD11b expressing cellsLECLERC CLAUDE·Filed 2011·Granted Jun 21, 2016·2 cites·22 claims
- 0349US9155783B2Agents and methods based on the use of the EDA domain of fibronectinLECLERC CLAUDE·Filed 2006·Granted Oct 13, 2015·0 cites·25 claims
- 0444US2006159697A1Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereofLECLERC CLAUDE·Filed 2005·Application pending·0 cites
- 0542US2006286613A1Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclaseLECLERC CLAUDE·Filed 2006·Application pending·0 cites
- 0640US2013121958A1Streptavidin and biotin-based antigen delivery systemLECLERC CLAUDE·Filed 2010·Application pending·0 cites
- 0738US2006019323A1Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclaseLECLERC CLAUDE·Filed 2004·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →